A double-blind, placebo controlled, randomized, parallel-group clinical trial with multiple dose treatment of anti-IL [interleukin] 15 human monoclonal antibody (AMG 714) in patients with active rheumatoid arthritis who have previously failed one or more disease modifying anti-rheumatic drugs

Trial Profile

A double-blind, placebo controlled, randomized, parallel-group clinical trial with multiple dose treatment of anti-IL [interleukin] 15 human monoclonal antibody (AMG 714) in patients with active rheumatoid arthritis who have previously failed one or more disease modifying anti-rheumatic drugs

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2007

At a glance

  • Drugs AMG 714 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top